WOCKHARDT
Back to Balance Sheet
|
WOCKHARDT Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹7,586 Cr | ₹7,070 Cr | ₹7,075 Cr | ₹7,670 Cr | ₹7,376 Cr |
What is the latest Total Liabilities ratio of WOCKHARDT ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹7,586 Cr |
| Mar2024 | ₹7,070 Cr |
| Mar2023 | ₹7,075 Cr |
| Mar2022 | ₹7,670 Cr |
| Mar2021 | ₹7,376 Cr |
How is Total Liabilities of WOCKHARDT Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹7,586 Cr | 7.30 | |
| Mar2024 | ₹7,070 Cr | -0.07 | |
| Mar2023 | ₹7,075 Cr | -7.76 | |
| Mar2022 | ₹7,670 Cr | 3.99 | |
| Mar2021 | ₹7,376 Cr | - | |
Compare Total Liabilities of peers of WOCKHARDT
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| WOCKHARDT | ₹21,908.3 Cr | -2.1% | -6.2% | 0.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹393,323.0 Cr | 1.7% | -5.7% | -7.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹160,825.0 Cr | 0.8% | -6.7% | 3.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹135,349.0 Cr | 0.6% | 4.3% | 24.4% | Stock Analytics | |
| CIPLA | ₹106,048.0 Cr | -4.7% | -12.3% | -7.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,494.0 Cr | 6.3% | -2.1% | -4.1% | Stock Analytics | |
WOCKHARDT Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| WOCKHARDT | -2.1% |
-6.2% |
0.4% |
| SENSEX | -1.7% |
-4.3% |
6.2% |
You may also like the below Video Courses